Zou et al. (Wang et al., 2019) found that IFN γ derived from immunotherapy-activated CD8+ T cells could down-regulate SLC3A2 and SLC7A11 levels, leading to decreased cystine uptake and enhanced tumor lipid oxidation and ferroptosis. The gene discussed is SLC7A11; the disease is neoplasm.